Medicines Company Suspends Clevelox Patient Enrollment
The Medicines Company has voluntarily suspended patient enrollment in its Clevelox (clevidipine) Phase III safety trials.
network
The Medicines Company has voluntarily suspended patient enrollment in its Clevelox (clevidipine) Phase III safety trials.